Medication info

Evastin Tablets 10/20 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Taeguk Pharmaceutical Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablets
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Expired

MFDS item code 201903091 · Approved 2019.05.13

This product's status changed to Expired on 2024.05.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg to 10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. For patients requiring less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels after an interval of 4 weeks or longer and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor closely when administering higher doses of this drug to these patients (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving verapamil, diltiazem, or dronedarone concomitantly with this drug should not exceed a dose of 10/10mg/day of this drug. Patients receiving amiodarone, amlodipine, or ranolazine concomitantly with this drug should not exceed a dose of 10/20mg/day of this drug.

Ingredients

Manufacturer
Taeguk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases caused by hypercholesterolemia
View approved original text

This medication is used as an adjunct to dietary therapy for lowering high total cholesterol, LDL cholesterol, Apo B protein, and triglycerides in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial, and mixed hyperlipidemia, as well as for increasing HDL cholesterol, the 'good' cholesterol. It can also be given alone to patients with homozygous familial hypercholesterolemia when other lipid-lowering therapies are not effective or cannot be used. This medication is used together with an appropriate diet that includes restrictions on saturated fats and cholesterol, and is prescribed when diet alone or non-drug measures are insufficient. Prior to treatment, secondary causes of hypercholesterolemia, such as diabetes or hypothyroidism, should be evaluated and treated as necessary. Regular monitoring of total cholesterol, LDL, HDL, and triglyceride levels is important to assess treatment progress. This medication helps reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg to 10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. For patients requiring less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels after an interval of 4 weeks or longer and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor closely when administering higher doses of this drug to these patients (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving verapamil, diltiazem, or dronedarone concomitantly with this drug should not exceed a dose of 10/10mg/day of this drug. Patients receiving amiodarone, amlodipine, or ranolazine concomitantly with this drug should not exceed a dose of 10/20mg/day of this drug.

Precautions

This medication may cause muscle adverse reactions, so if muscle pain or weakness occurs, it should be reported to a physician immediately. This medication should not be used in patients with poor liver function, liver disease, or in pregnant or nursing women. Additionally, taking this medication with certain other medicines may increase the risk of muscle damage, so it is essential to inform the doctor of any other medications being taken. Elderly patients or those with certain myopathies need to exercise extra caution when using this medication. During treatment, it is advisable to regularly check blood tests to monitor muscle and liver conditions. If there are unexplained muscle pain, tenderness, or weakness while taking this medication, it should be stopped immediately and consult a healthcare professional. This medication should not be used in women who are planning to become pregnant or who may be pregnant, and it should be discontinued immediately upon confirmation of pregnancy. Women who are nursing should also be advised to stop breastfeeding while taking this medication. There is insufficient evidence of safety and efficacy for use in children and adolescents, so it should be used with caution. There is no specific antidote for overdose, but appropriate treatment should be provided based on symptoms.

Side effects

  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • muscle pain
  • limb pain
  • fatigue
  • abdominal pain
  • viral infection
  • pharyngitis
Show 98 more
  • sinusitis
  • joint pain
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • itching
  • rash
  • muscle cramp
  • myopathy
  • rhabdomyolysis
  • specific cranial nerve dysfunction
  • taste disturbance
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmare
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • fibromyalgia
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • appetite loss
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated γ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, storing the medication at room temperature between 1°C and 30°C will maintain its efficacy.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablets

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.